Ethyl 3-(2-(((4-(N-((hexan-3-yloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate (Dabigatran Impurity), 97%, 50mg

(R,Z)-tert-Butyl (1-(7-(3-bromobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate (Linagliptin Impurity), 98%, 50mg

Phosphoenolpyruvate, monocyclohexylammonium salt, 95%, 25g

8-Anilino-1-naphthalenesulfonic acid,ammonium salt, 95+%, 1g

Tetrakis(2-methoxyethoxy)silane, 95+%, 5g

Ethyl 2-(3-benzoylphenyl)propanoate, 98%, 100mg

7-Fluoro-6-nitro-1,2,3,4-tetrahydroisoquinoline hydrochloride, 95.0%, 1g

Y-320>98.0%(HPLC)25mg

Ethyl 4,6-dichloro-1H-indole-2-carboxylate, 97.0%, 5g

D(+)-Maltose monohydrate, min. 92%, for biochemistry, 100 g, plastic packaging.

(S)-1-(4-Bromophenyl)-N-methylethanamine hydrochloride, 95.0%, 100mg

Bis(1,5-cyclooctadiene)diiridium(I) dichloride, 98.0%, 100mg

Ethyl 4,5-bis(2-methoxyethoxy)-2-nitrobenzoate, 95.0%, 1g